Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: an overview of obstacles and opportunities

YF Chen, J Li, LL Xu, MA Găman… - World Journal of Clinical …, 2023 - pmc.ncbi.nlm.nih.gov
As an important treatment for acute myeloid leukemia, allogeneic hematopoietic stem cell
transplantation (allo-HSCT) plays an important role in reducing relapse and improving long …

Effects of quercetin on ovarian function and regulation of the ovarian PI3K/Akt/FoxO3a signalling pathway and oxidative stress in a rat model of cyclophosphamide …

S Zheng, M Ma, Y Chen, M Li - Basic & Clinical Pharmacology …, 2022 - Wiley Online Library
To investigate the ability of quercetin to improve ovarian function and inhibit ovarian
oxidative stress through the PI3K/Akt/FoxO3a signalling pathway in a rat model of premature …

A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia

AA van de Loosdrecht, S van Wetering… - Cancer Immunology …, 2018 - Springer
In elderly acute myeloid leukemia (AML) patients post-remission treatment options are
associated with high comorbidity rates and poor survival. Dendritic cell (DC)-based …

The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo

SR Lin, CH Chang, MJ Tsai, H Cheng… - … advances in chronic …, 2019 - journals.sagepub.com
Dipeptidyl peptidase IV (DPP-4), an incretin glucagon-like peptide-1 (GLP-1) degrading
enzyme, contains two forms and it can exert various physiological functions particular in …

Hematopoietic stem cell transplantation and quality of life during the first year of treatment

ACB Marques, AP Szczepanik… - … latino-americana de …, 2018 - SciELO Brasil
Objective: to evaluate the quality of life of adult patients with hematological cancer
comparing Hematopoietic Stem Cell Transplantation modalities during the first year of …

Retrospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease—an analysis from transplant centers across Europe

R Langer, A Lelas, M Rittenschober… - Frontiers in …, 2024 - frontiersin.org
Introduction Chronic graft-versus-host disease (cGvHD) is a serious late complication of
allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods This multicenter …

Top ten tips palliative care clinicians should know about caring for patients with hematologic malignancies

JA Webb, AM Foxwell, CA Jones… - Journal of palliative …, 2019 - liebertpub.com
Hematologic malignancies differ in several important ways from solid organ cancers, and
warrant a unique approach to palliative care (PC) integration. As PC has moved upstream …

Qualidade de vida nos primeiros seis meses pós-transplante de células-tronco hematopoéticas

ACB Marques, SFFS Proença… - Texto & Contexto …, 2017 - SciELO Brasil
Objetivo: avaliar a qualidade de vida dos pacientes adultos com câncer hematológico
submetidos ao transplante de células-tronco hematopoéticas nos primeiros seis meses e …

Quality of life of patients with graft-versus-host disease (GvHD) post-hematopoietic stem cell transplantation

SFFS Proença, CM Machado, RCFP Coelho… - Revista da Escola de …, 2016 - SciELO Brasil
OBJECTIVE Assessing the quality of life of adult patients with hematological cancer in the
100 days after transplantation of hematopoietic stem cells and verifying whether the variable …

Survival of patients with acute myeloid leukemia after allogeneic stem cell transplantation: an experience in develo** country

M Mehdizadeh, V Bolourian, G Zamani… - … Oncology and Stem …, 2022 - pmc.ncbi.nlm.nih.gov
Background: Allogeneic stem cell transplantation (allo-SCT) is the highest potential
treatment for long-term survival as post-remission therapy for acute myeloid leukemia (AML) …